Cite
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients.
MLA
Rocci, Alberto, et al. “MET Dysregulation Is a Hallmark of Aggressive Disease in Multiple Myeloma Patients.” British Journal of Haematology, vol. 164, no. 6, Mar. 2014, pp. 841–50. EBSCOhost, https://doi.org/10.1111/bjh.12719.
APA
Rocci, A., Gambella, M., Aschero, S., Baldi, I., Trusolino, L., Cavallo, F., Gay, F., Larocca, A., Magarotto, V., Omedè, P., Isaia, G., Bertotti, A., Liberati, A. M., Catalano, L., De Rosa, L., Musto, P., Vallone, R., Falcone, A., Drandi, D., & Ladetto, M. (2014). MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients. British Journal of Haematology, 164(6), 841–850. https://doi.org/10.1111/bjh.12719
Chicago
Rocci, Alberto, Manuela Gambella, Simona Aschero, Ileana Baldi, Livio Trusolino, Federica Cavallo, Francesca Gay, et al. 2014. “MET Dysregulation Is a Hallmark of Aggressive Disease in Multiple Myeloma Patients.” British Journal of Haematology 164 (6): 841–50. doi:10.1111/bjh.12719.